Suchergebnisse - "Bhagani, Sanjay"

PubPharm (17)

1

Tocilizumab in Hospitalized Patients With COVID-19 Pneumonia

enthalten in: bioRxiv.org | 2024

von Rosas, I. | Bräu, N. | Waters, M. | +20

2

Preserved C-reactive protein responses to blood stream infections following tocilizumab treatment for COVID-19

enthalten in: bioRxiv.org | 2023

von Wey, E. | Bristow, C. | Nandani, A. | +10

3

Nebulized recombinant tissue plasminogen activator (rt-PA) for acute COVID-19-induced severe respiratory failure: an exploratory proof of concept trial

enthalten in: Preprints.org | 2023

von Chowdary, P. | Agarwal, B. | Peralta, M. | +36

4

Nebulized Recombinant Tissue Plasminogen Activator (rt-PA) for Acute COVID-19-Induced Respiratory Failure : An Exploratory Proof-of-Concept Trial

enthalten in: Journal of clinical medicine | 2023

von Chowdary, P. | Agarwal, B. | Peralta, M. | +36

5

Tixagevimab-cilgavimab for treatment of patients hospitalised with COVID-19 : a randomised, double-blind, phase 3 trial

enthalten in: The Lancet. Respiratory medicine | 2022

von ACTIV-3–Therapeutics for Inpatients with COVID-19 (TICO) Study Group | Ginde, A. | Paredes, R. | +98

CommentIn: Lancet Respir Med. 2022 Oct;10(10):928-930. - PMID 35817073

6

Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19 : A Randomized Controlled Trial

enthalten in: Annals of internal medicine | 2022

von ACTIV-3/TICO Study Group | Barkauskas, C. | Mylonakis, E. | +98

CommentIn: Ann Intern Med. 2023 Feb;176(2):eL220455. - PMID 36802894

7

Effect of Molnupiravir on Biomarkers, Respiratory Interventions, and Medical Services in COVID-19 : A Randomized, Placebo-Controlled Trial

enthalten in: Annals of internal medicine | 2022

von Johnson, M. | Puenpatom, A. | Moncada, P. | +13

8

Tocilizumab in patients hospitalised with COVID-19 pneumonia : Efficacy, safety, viral clearance, and antibody response from a randomised controlled trial (COVACTA)

enthalten in: EClinicalMedicine | 2022

von Rosas, I. | Bräu, N. | Waters, M. | +34

9

Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients

enthalten in: The New England journal of medicine | 2022

von Jayk Bernal, A. | Gomes da Silva, M. | Musungaie, D. | +120

CommentIn: N Engl J Med. 2022 Feb 10;386(6):592-593. - PMID 34914869

10

Randomized Trial of Molnupiravir or Placebo in Patients Hospitalized with Covid-19

enthalten in: NEJM evidence | 2022

von Arribas, J. | Bhagani, S. | Lobo, S. | +17